Pharma Journalist -

AbbVie and ADARx Pharmaceuticals, a late clinical-stage biotechnology company developing next-generation RNA therapeutics, announced a collaboration and license option agreement to…
Read More...

Recipharm and ProductLife Group (PLG) announced a strategic collaboration aimed at supporting (bio)pharmaceutical companies in accelerating time to clinical trials and market approval…
Read More...

LONDON, UK – 24–25 June 2025 Projected to reach $1,139.4 billion by 2029, the injectable drug delivery market is rapidly growing—but what’s driving this evolution? From complex…
Read More...

Roche, the Breast International Group (BIG), Institut Jules Bordet Clinical Trials Support Unit and Frontier Science Foundation, announced today statistically significant final overall…
Read More...

AstraZeneca’s inhaled medicine Trixeo Aerosphere has become the first pressurised metered-dose inhaler (pMDI) to be approved in the UK using a next-generation propellant with near-zero…
Read More...

Biodexa Pharmaceuticals PLC, a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, announced…
Read More...

Beam Therapeutics Inc. announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) designation to BEAM-302, a…
Read More...

Novo Nordisk presented data from the phase 3 REAL8 basket study, which showed that once-weekly Sogroya (somapacitan) was non-inferior to the once-daily growth hormone Norditropin…
Read More...

Amneal Pharmaceuticals, Inc. and Apiject Systems, Corp. announced a strategic collaboration to expand domestic production of Apiject’s BFS-based injectable platform at Amneal’s…
Read More...

HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram disease-driving cell states for rare, common,…
Read More...